Andrei Shustov

Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY.

Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO.

Orchid Cellmark, Inc. provides DNA testing services. It generates genetic profile information by analysing an organism's unique genetic identity. The firm also offers non-DNA forensic laboratory services. The company was founded on March 8, 1995 and is headquartered in Princeton, NJ.

Perceptive Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph “Joe” Edelman in 1999. provides investment advice to private funds, separate accounts, and co-investment vehicles. Investors in the client accounts and co-investment vehicles consist primarily of institutional investors, financial institutions, other investment funds, and high-net-worth individuals.

Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY.

Resolve Surgical Technologies, Inc. develops and manufactures medical devices. It provides products in the spine, biologics, orthopedics, and cardiothoracic markets. The company was founded in 1992 and is headquartered in Marquette, MI.

Titan Spine, Inc. designs and manufactures inter body fusion devices for the spine. The firm specializes in surface technology, medical devices, interbody spinal fusion devices. The company was founded by Peter Ullrich and Kevin W. Gemas in 2005 and is headquartered in Mequon, WI.

Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million.

University of Nevada functions as a college and university. It provides education, research, scholarship, creative activities, and clinical services. The company was founded on September 10, 1957 and is headquartered in Las Vegas, NV.

Mayo Clinic Jacksonville provides health care services. It specializes in transplant program, including bone-marrow, heart-lung, kidney, and pancreas. The company was founded in 1986 and is headquartered in Jacksonville, FL.

TomoTherapy, Inc. manufactures and provides radiation treatment systems for advanced radiation therapy. It provides radiation treatment services for cancer patients with its TomoTherapy Hi·Art System, which changes the intensity of the radiation beam so that it adapts to the shape of the tumor. The firm's system focuses on killing cancer cells while sparing healthy tissue. The company was founded by Thomas Rockwell Mackie and Paul J. Reckwerdt in 1997 and is headquartered in Madison, WI.

Jacksonville Zoological Society, Inc. operates as a non-profit organization that engages in the management of a zoo. The company is headquartered in Jacksonville, FL.

The Morgridge Institute for Research, Inc. is a biosciences research institution. The private company is based in Madison, WI. The CEO of the company is Brad Schwartz.

Numoda Capital Innovations LLC (Numoda Capital) is a venture capital subsidiary of Numoda Corp founded in 2009. The firm is headquartered in Philadelphia, Pennsylvania.

Westwicke Partners LLC operates as a strategic communications and advisory firm that is focused exclusively on healthcare. It offers digital branding, crisis communications, and capital markets advisory. The company was founded by Robert East and Mark Klausner in 2006 and is headquartered in Baltimore, MD.

Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom.

Prevail Partners LLC (Prevail Partners) is a venture capital subsidiary of Prevail Infoworks,Inc founded in 2015. The firm is headquartered in Philadelphia, Pennylvania.

Vivex Biologics, Inc. is a regenerative medicine company that specializes in developing naturally sourced treatment options and solutions to improve clinical, surgical, and therapeutic patient care through innovation. The company is based in Atlanta, GA and has subsidiaries in the United States. The company leverages the resources of the nation's oldest civilian tissue bank to channel the body's inherent healing qualities and provide medical professionals and patients with innovative treatment options for a broad range of indications. With tissue damage resulting from a variety of diseases, direct injury, and trauma, there is a significant need for advanced solutions. The company was founded by Tracy S. Anderson, and Peter L. Wehrly has been the CEO of the company since 2019.

Health Scholars, Inc. engages as a cloud-based, VR-ready training platform for the management, delivery, and analysis of clinical training. Its solutions include virtual reality training, and simulation management. The company was founded by Brian Gillett in 2017 and is headquartered in Westminster, CO.

Starton Therapeutics, Inc. is a clinical-stage biotechnology platform company that focuses on transforming standard of care therapies with proprietary continuous delivery technology. The company is based in Paramus, NJ. The company's goal is to provide continuous treatment to people with cancer so they can live better and longer. Starton's proprietary transdermal technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. The company was founded in 2017 by Pedro Lichtinger, who has been the CEO since 2017.